phloretin has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phloretin treatment significantly restrained cell viability and metastasis, induced DNA injury and ROS accumulation, and triggered mitochondrial-dependent apoptosis in PCCs." | 1.91 | Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity. ( Bai, Y; Deng, J; Huang, G; Jin, G; Li, G; Ruan, Q; Wen, C; Wen, Z; Yang, X; Yuan, Z, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruan, Q | 1 |
| Wen, C | 1 |
| Jin, G | 1 |
| Yuan, Z | 1 |
| Yang, X | 1 |
| Wen, Z | 1 |
| Huang, G | 1 |
| Li, G | 1 |
| Deng, J | 1 |
| Bai, Y | 1 |
1 other study available for phloretin and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Phloretin-induced STAT3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neop | 2023 |